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Host immune status in uremia. IV. Phagocytosis and inflammatory
response in vivo. Infection is a frequent complication and cause of death
in renal failure, but the association between uremia, depressed immune
status, and susceptibility to infection is far from proven. In the present
studies, the effect of uremia on the inflammatory response and phago-
cytic ability was investigated in an animal model. The inflammatory
response, as measured by the ability of leukocytes to mobilize into
subcutaneous implanted sponges, was impaired at 6 hr but was normal
24 hr after implantation. The peripheral blood response of uremic
animals to the leukocytosis promoting protein from Bordetella pertussis
was similar to that of control animals. Reticuloendothelial clearance of
labelled albumin was unimpaired but catabolism of this substance was
reduced significantly in uremic animals. The ability of the uremic host
to clear an intravenous challenge of virus was also depressed. Phago-
cytic and bactericidal capability of polymorphonuclear (PMN) leuko-
cytes, measured in vitro by latex ingestion and phagocytosis and killing
of Staphylococcus aureus, was normal. PMN phagocytic function in
vivo was determined by the clearance of viable Escherichia coil from
subcutaneously implanted sponges and no significant difference be-
tween control and uremic groups was found. These studies have further
defined the effect of uremia on immune mechanisms and support our
contention that uremia per se is not a major factor contributing to the
compromised immune status in this host.
Etat immun de l'hOte dans l'urémie. IV. Phagocytose et reponse
inflammatoire in vivo. L'infection est une complication frequente et une
cause de mort lors de l'insuffisance rénale, mais l'assocation entre
urémie, depression de l'immunité et susceptibilité, a l'infection est loin
d'être prouvée. Dans les etudes présentes, l'effet de l'urémie sur la
reponse inflammatoire et Ia capacité phagocytaire a été étudié chez un
modèle animal. La réponse inflammatoire, mesurée par Ia capacité des
leucocytes de se mobiliser dans des éponges implantées sous Ia peau,
était diminuée a 6 hr, mais était normale 24 hr après l'implantation. La
réponse sanguine periphérique des animaux urémiques a la protéine
promouvant Ia leucocytose provenant de Bordetella pertussis était
identique a celle d'animaux contrôles. La clearance réticuloendothé-
hale d'albumine marquee n'était pas altérée, mais le catabolisme de
cette substance était significativement élevé chez les animaux uré-
miques. La capacité de l'hôte urémique a éliminer une charge intravein-
euse de virus était egalement diminuée. La capacité phagocytaire et
bactericide des leucocytes polymorphonucleaires (PMN), mesurés in
vitro par l'ingestion et Ia phagocytose de latex et Ia capacité de tuer le
Staphylococcus aureus, etait normale. La fonction phagocytaire des
PMN in vivo a été déterminée par la clearance de Escherichia coil
viables a partir d'eponges implantees sous Ia peau, et aucune difference
significative entre les groupes contrôles et urémiques n'a été trouvée.
Ces etudes ont permis de mieux définir I'effet de l'urémie sur les
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mécanismes immuns et ont confirmé notre impression que l'urémie per
se n'est pas un facteur majeur contribuant a un état immun compromis
chez cet hôte.
Infection is a frequent complication and cause of death in
renal failure. In chronic renal failure up to 60% of the patients
suffer from serious infection which contributes to death in 38%
of patients [1]. Acute renal failure following trauma or surgery
[2, 31 is also associated with a high incidence of infectious
complications and it is not surprising that most physicians
accept that uremia impairs immunity and predisposes the host
to infection. Evidence for an impairment of immune capability
can certainly be found in the literature but on closer examina-
tion the association between uremia, depressed immune status,
and susceptibility to infection is far from proven. In effect, the
majority of the clinical studies to date have characterized the
overall immune status of the patient with endstage renal disease
without being in a position to comment on the immunomodula-
tory effect of uremia per se. The principal problem is that other
factors besides uremia may contribute to the immune compro-
mised status of these patients. Drug therapy, particularly poiy-
pharmacology, the relative age of the patient, varying degrees
of malnutrition, duration of renal failure, and surgical manipula-
tions all complicate any attempt to demonstrate a direct associ-
ation between uremia and a decreased resistance to infection.
In an effort to define the effects of uremia on immune status
we have carried out several experiments using a carefully
characterized model of chronic uremia [4—7J. This model pre-
sents many advantages, and it has been possible to either
standardize or eliminate the variables complicating related
studies in humans. We utilized a series of complementary in
vivo and in vitro assays to study the effect of uremia on host
inflammatory response and phagocytic systems.
Methods
Animals. Male rats, obtained from an inbred Dark Agouti
(DA) strain and weighing between 200 and 250 g, were used in
these experiments.
Induction of uremia. A reproducible state of severe stable
uremia was induced by controlled resection of the renal paren-
chyma. The condition was produced by the removal of 88%
2% of the renal tissue, that is, the poles, top and 2-mm slices
from the dorsal and ventral aspects of the left kidney were
removed followed by total removal of the right kidney 7 days
later. Animals subjected to this treatment had blood urea levels
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greater than 150 mg/dl (> 25 mmoles/liter) and GFR's 10 to 20%
of normal. Sham-operated animals were used as controls. We
surgically exposed the left kidneys of the animals and removed
thin slices of tissue from the lateral cortical surface. Seven days
later the right kidney was exposed surgically and then replaced.
This procedure has been described in detail elsewhere [71. The
biochemical and hematological status of each animal was as-
sessed at the end of each experiment.
Measurement of the inflammatory response
Mobilization of cells into subcutaneously implanted sponges.
Cylindrical sponges (2.5 cm x 1 cm, 40 1 mg) were cut from
polyurethane absorbent foam packing (Tasman Vaccine Labo-
ratories, Upper Hutt, New Zealand). The sponges were washed
in distilled water and sterilized by autoclaving in physiological
saline. Before implantation the fluid was removed by squeezing
the sponge in a sterile plastic syringe. An incision was then
made in the dorsal midline, the facia retracted by blunt dissec-
tion, and a sponge implanted in either side of the midline in the
subcutaneous space. Care was taken to observe strict aseptic
techniques at all times. After implantation the wound was
sutured and an antibiotic spray applied to reduce the risk of
infection. Cells were harvested from sponges 6, 15, 24 hr and 5
days after implantation. After washing in Hanks' basic salt
solution (HBSS) total and differential leukocyte counts were
carried out.
Determination of serum complement. The 50% hemolysis
endpoint procedure developed by Tailiaferro and Tailiaferro [8]
and described in detail by Campbell et al [9] was used to
determine hemolytic complement activity. Rabbit antisheep
erythrocyte sera (Burroughs Wellcome) was titrated to deter-
mine the optimum concentration for use. Eight dilutions of each
sample were used to determine the ordinate intercept. The
slope of the line was determined by computer analysis using the
sum of least squares. Since the ordinate intercept is the
reciprocal of the log dilution of complement that would result in
50% hemolysis, the antilog of this figure gave the complement
titer as the 50% endpoint.
Quantitative analyses of C3 were carried out using rocket
electrophoresis. The method was essentially the same as that
developed by Laurell [10] and described by Weeke [11] except
that the plate was run for 3 to 4 hr at 150 volts with a current of
60 to 80 milliamps.
Response to leukocytosis-promoting protein (Bordetella per-
tussis). Challenge with Bordetella pertussis results in a marked
leukocytosis and lymphocytosis in the normal host. A compo-
nent comprising four polypeptide units is believed to be the
active material [12]. A killed suspension of the organism
containing 2 x 1010 organisms per vial was obtained from the
Commonwealth Serum Laboratories, Melbourne, Australia.
Animals were challenged with an intravenous injection of 4 ><
1010 organisms. Blood was obtained for peripheral blood leuko-
cyte counts at regular intervals from the tip of the tail. Blood
was collected into 2% acetic acid and leukocyte numbers
counted in a Neubauer counting chamber. A differential leuko-
cyte count was carried out on a Wright stained blood film.
Measurement of phagocytosis
Mononuclear phagocytic system. Clearance and catabolism
of 1251-labelled albumin. The phagocytic and catabolic capacity
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Fig. 1. RES function: plot of'251 and 1j activity in the serum of a rat
injected with I mg 1251-labelled MiAHSA (specific activity—1O.9 ,uCi/
mg) and 4 /.LCi free l3lj Symbols: •—•, total 125J in serum;
X—X, protein-free 1251 in serum; 0 0, total 1311 in serum.
of mononuclear phagocytic cells of the reticuloendothelial
system (RES) was assessed using '251-labelled microaggregated
human serum albumin (1251 MiAHSA) which was prepared
according to the method of ho et al [13] and labelled using the
lactoperoxidase method. The phagocytic rate was also mea-
sured using the method of ho et al. Calculation of the catabolic
rate was based on the model proposed by Bouveng, Schildt, and
Sjoqvist [14]. A brief description of the methodology follows:
Preparation of MiAHSA: Four milliliters of 25% normal human
albumin (Commonwealth Serum Laboratories) were made of up
to 33.3 ml with normal saline to give a final concentration of 3%
albumin. The pH was adjusted to 10 with 2 N NaOH. The
mixture was incubated at 70°C for 20 mm in a shaking water
bath oscillating at 100 rpm. The temperature was then increased
to 79°C and incubation continued for an additional 15 mm. The
albumin was cooled under running water and the pH was
adjusted to neutrality with 2 N HCI. Sterilization of the microag-
gregated albumin was performed by filtration. The material was
stored at 4°C. Iodine labelling: 6 mg of lactoperoxidase, (Sigma
Chemical Co., St. Louis, Missouri) in 0.5 ml saline was added
to 3.5 ml of a 30 mg/ml solution of MiAHSA. Carrier-free 1251
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2.5 mCi, and 0.13 ml of a 1:1500 dilution of H202 were added to
the mixture. This preparation was incubated at 30°C for 15 mm
and the free 125! was removed by fractionation on a 20-mi Biogel
P6 column (BioRad Laboratories, Richmond, California). The
amount of unincorporated 125j was measured using paper
chromatography and was found to be 2.8%. The specific
activity was 10.9 tCi/mg.
Measurement of phagocytosis and catabolism. Animals were
injected intravenously via the lateral tail vein with 1 mg 125j
MiAHSA and 4 Ci free 1311 Accurately timed blood samples
were taken from the tip of the tail into microhematocrit tubes 5,
10, 15, 20, 25, 30, 40, 50, 60, and 80 mm after injection of 1251
MiAHSA. The tubes were spun and 25 d of serum added to 400
d of saline. Diluted serum, 166.6 l, was put into a counting
tube for estimation of the whole 131! and 125! counts. A further
200 jd of diluted serum was transferred into a 0.5-mi microcen-
trifuge tube and the protein precipitated by the addition of 40 tl
of 20% perchloric acid. Following incubation of 1 hr at 4°C, the
tubes were centrifuged and 200 tl of the supernatant removed
for counting. This allowed the amount of protein-bound and
protein-free 1251 to be calculated. The samples were counted for
sufficient time to collect at least 10,000 counts.
The compartment model developed by Palmer, Rifkind, and
Brown [15] was used to estimate the phagocytic rate. Using the
model a bi-phasic exponential curve is obtained when the log of
the protein-bound serum 125J counts is plotted against time. The
phagocytic activity is then expressed as the slope of the initial
rapid phase corrected for the slower second phase. The rate of
appearance of free 125! in the blood is related to the catabolic
activity of the phagocytic cells. Iodine is lost continuously from
the plasma and the disappearance rate of the free 131J was used
to correct blood levels of free 1251 for such losses. A good
straight line fit is obtained when the log of the corrected protein-
free serum 1251 counts, obtained between 20 and 80 mm after the
injection of 1251 MiAHSA, is plotted against time. The catabolic
activity is expressed as the slope of this line. The kinetics of this
assay and a computer program designed to calculate the phago-
cytic and catabolic rate have been described in detail by
Eriksson and Schildt [16]. Data from a representative experi-
ment performed on a normal rat is present in Figure 1.
Elimination of viable bacteriophage ØX174. Bacteriophage
ØX174 was obtained from Miles Laboratories Inc., Elkhart,
Indiana, as a suspension in 5 x 102 M sodium borate pH 9.1
and 2 X M ethyldiamine tetra-acetic acid. The bacteri-
ophage was assayed by the conventional soft agar layer method
to determine the number of plaque-forming units (PFU) per
milliliter of suspension [17]. For clearance studies bacteri-
ophage ØX174 was diluted to 1 x 1011 PFU per milliliter in
trypticase soy broth (TSB). Each animal was injected with 5 x
1010 PFU into the ventral tail vein, and blood samples were
taken from the tip of the tail immediately and 2, 7, 24, 32, 48, 56
and 72 hr after injection. Blood, 10 d, was sampled into TSB.
Suitable dilutions were made to give a countable number of
PFU for each sample. The number of PFU per milliliter was
determined after incubation at 37°C for 4 hr. The rate of
decrease of viable circulating bacteriophage was then assessed
by calculating the half life of phage disappearance.
Polymorphonuclear phagocytic system. In vivo clearance of
Escherichia coli from subcutaneously implanted sponges.
Sponges were prepared as previously described. An incision
was made at either side of the dorsal midline with the facia
retracted by blunt dissection and a sponge implanted in each
subcutaneous space. Care was taken to observe strict aseptic
techniques at all times. Once in place each sponge was infected
with 500 50 E. coli 075 in 10 1.d saline and the incision closed.
At selected time intervals after implantation the sponges were
aseptically removed, weighed, and then squeezed in 9 ml of
saline using a rotating teflon pestle in a heavily walled glass
tube. Nutrient agar pour plates were made from serial tenfold
dilutions to obtain the bacterial count per sponge after correct-
ing for the amount of inflammatory fluid in the sponge. The
bacterial count was expressed as the log number of bacteria per
sponge.
In vitro killing of Staphylococcus aureus. Sponges were
prepared and implanted as already described and carefully
removed after 15 hr. Swabs were taken from the wound and
plated onto blood agar for aerobic and anaerobic culture. Each
sponge was also lightly touched on a blood agar plate and
cultured in the same way. Infection rarely occurred, but if it
was demonstrated, the results from animals showing bacterial
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Fig. 2. Hematology: the effect of uremia on
leukocytes 2 and 4 weeks after induction of
uremia. Abbreviations: WBC, white blood cell
count; Seg Neut, segmented neutrophils; Con,
control; Sh, sham-operated; Ur, severely
uremic.
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contamination were excluded from the study. The two sponges
from each animal were squeezed gently with gloved fingers into
5 ml of Hanks' balanced salt solution (HBSS) and washed once.
The ability of the sponge-derived neutrophils to phagocytose
and kill Staphylococcus aureus was determined using lysosta-
phin and the method described by Tan, Watanakunakorn, and
Phair [181. In brief, neutrophils, serum, and the micro-orga-
nisms are incubated together for 120 mi Lysostaphin is added
to one aliquot to lyse extracellular micro-organisms. Phagocytic
cells in both aliquots are then lysed and the total number of
viable micro-organisms remaining are determined.
In vitro phagocytosis of latex particles. To measure in vitro
phagocytosis, 2 x l0 sponge derived cells obtained 6, 15, 24 hr
and 5 days after implantation were resuspended in 200 p1 of
Hanks' BSS containing 5 p1 of 1% Dow latex particles (0.804 s,
Dow Chemical Company, Indianapolis, Indiana), and 200 1.d rat
serum. The preparation was incubated at 37°C for 1 hr. Cells
were washed twice in Hanks' BSS containing 10% fetal calf
serum. The cell concentration was adjusted to 2 x io per
milliliter and pelleted onto a glass slide by cytocentrifugation
(Shandon Scientific Company, London, United Kingdom).
Slides were air-dried, fixed in methanol, and stained with
Wright's stain.
Statistical evaluation. A statistical evaluation of the results
was carried out on a PDP1 1 computer using the Wilcoxon sum
of ranks test for nonparametric data.
Hematological and biochemical status
Hematology. Samples of peripheral blood were taken from
sham-operated and severely uremic rats 2 and 4 weeks after the
induction of uremia. Samples from control (unmanipulated) rats
were also obtained. Total leukocyte counts were made using a
Coulter counter and the relative numbers of segmented neutro-
phils and lymphocytes were determined. The results are shown
in Figure 2. Two weeks after the second operation both groups
of manipulated animals showed a significant increase in the
total leukocyte numbers. At 4 weeks the sham-operated animals
had returned to normal while the uremic rats still had elevated
counts. When the differential leukocyte count at 2 weeks was
examined, an increase in the absolute numbers of neutrophils
was found while the number of lymphocytes was decreased.
Four weeks after surgery these differences were no longer
evident.
Biochemistry. Blood samples for determination of blood urea
and creatinine levels were taken at the end of each phase of the
experiment. The levels were measured using standard autoana-
lytical methods. In all animals that had undergone partial
nephrectomy the blood urea concentration was in excess of 150
mgldl (>25 mmoles/liter) thus confirming the severely uremic
status of this group. The urea levels in sham-operated animals
were within the normal range. Individual results are not report-
ed here, but a detailed characterization of the renal biochemical
and functional parameters of the uremic model has been pub-
lished [7].
Effect of uremia on the inflammatory response
Mobilization of cells. Two sponges were implanted into each
animal in groups of sham-operated and chronically uremic rats.
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Fig. 3. Chemotaxis: response of leukocytes to subcutaneously implant-
ed polyurethane sponges in sham-operated and severely uremic rats.
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Sponges were removed from animals in each group 6, 15, 24 hr
and 5 days after implantation. At 6-hr cell migration in the
uremic group was impaired significantly (P < 0.01) and the
mean number of mobilized cells (1.5 x 106) was 50% of the
control group (Fig. 3). Over 90% of the migrant cells from both
groups were identified as neutrophils. Similar results were
observed 15 hr after the challenge. Cell mobilization (95%
neutrophils in both groups) was again significantly impaired in
the uremic group (P <0.02). Twenty-four hours after implanta-
tion, however, there were no significant differences in the
number -of cells found in sponges from sham-operated and
uremic groups. The results were similar 5 days after challenge.
Serum complement levels. Total complement and C3 levels
were determined in 15 sham-operated and 15 uremic animals 3
weeks after the induction of uremia. The mean and SD for
hemolytic complement activity (CH5O) was 195 31 for sham-
operated animals and 213 47 for the severely uremic group.
C3 levels were 125 10% and 127 12%, respectively. There
was no significant difference between the two groups in either
assay.
Response to leukocytosis-promoting protein (Bordetella per-
tussis). Two groups of animals (9 sham-operated and 14 severe-
ly uremic) were challenged intravenously with 1 ml of Borde-
tella pertussis vaccine containing 4 x 1010 killed organisms.
Blood for peripheral leukocyte and differential counts was
collected at intervals during the following 14 days. Animals in
both groups challenged with Bordetella pertussis showed an
increase in leukocyte numbers which reached a peak 24 hr later.
Granulocyte numbers increased 3.6- and 4.2-fold in the sham-
operated and uremic animals, respectively, but returned to
normal 4 days after the challenge. Lymphocyte numbers
reached a peak between 4 and 7 days after the challenge. A 1.9-
and twofold increase in sham and uremic groups, respectively,
was found, and, after 14 days lymphocyte numbers were still
elevated. No statistically significant differences between the
responses of the two groups were found at any of the time
points examined (Fig. 4).
Effect of uremia on the phagocytic system
Mononuclear phagocytic system. Clearance and catabolism
of 125j MiAHSA. Clearance and catabolism of 1251-labeled
\
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Time, days after challenge
Fig. 6. RES function: elimination of ØX174 from sham-operated and
uremic rats. The data is the mean from ten sham-operated and 12
severely uremic animals. Symbols are: x, sham-operated rats; ®,
uremic rats.
albumin was quantitated in 13 untreated control animals, 9
sham-operated, and 10 animals with severe chronic uremia. No
significant differences in the clearance of '251-labelled albumin
was demonstrated between the three groups. Catabolic function
in the severely uremic group however was reduced significantly
(P < 0.01) (Fig. 5).
Elimination of viable bacteriophage ØX174. Ten sham-oper-
ated and 12 severely uremic animals were challenged with an
intravenous inoculation of 5 x lOb PFU of the bacteriophage
ØX174. Blood samples were taken immediately before and 2, 7,
24, 32, 48, 56 and 72 hr after the challenge. Figure 6 shows the
mean elimination curve of the groups. The best fit analysis of
the data showed rate constants (k values) of —0.192 for the
sham-operated group and —0.177 for the severely uremic ani-
mals with half lives of 3.6 and 3.92, respectively. Although
these differences were small, the results showed a decrease in
the ability of the uremic animals to clear a challenge of
bacteriophage (P < 0.05).
Polymorphonuclear phagocytic system. In vivo clearance of
E. coli from subcutaneously implanted sponges. The time
course of the experimental infection was followed in 42 severely
uremic animals and 40 sham-operated controls. The bacterial
numbers in the sponges were determined 12, 24, 72 and 96 hr
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Table 1. Effect of chronic uremia on the volume of inflammatory infiltrate in subcutaneously implanted sponges
Sham Uremic Sham Uremic Sham Uremic Sham Uremic
12 hr 24 hr 72 hr 96 hr
Number of animals 10 10 15 16 5 6 10 10
Milliliters of inflammatory fluid 0.54 0.54 0.73 0.76 1.12 1.29 1.17 1.25
per sponge so 0.11 0.11 0.11 0.14 0.16 0.26 0.17 0.17
after implantation. The number of animals used at each time
period and the mean volume of the inflammatory fluid for each
group is shown in Table 1. The volume gradually increased
reaching a plateau at 3 days. There was no difference in the
amount of infiltrate between the sham or uremic animals at the
four time periods studied. Likewise, when the bacterial num-
bers in the sponges from the two groups were compared, there
was no significant difference (Fig. 7).
In vitro phagocytosis and killing of Staphylococcus aureus.
Cells were obtained from sponges 15 hr after implantation in
sham-operated and uremic animals. There was no significant
difference in the ability of cells from these two groups to ingest
and kill an inoculum of Staphylococcus aureus. A mean of 56
and 59% micro-organisms were phagocytosed by the sham-
operated and severely uremic group, respectively, and both
groups killed 99% of the ingested micro-organisms.
In vitro phagocytosis of latex particles. Cells were obtained
from sponges 15 hr after implantation in both uremic and sham
animals. Ninety-five percent of the cells obtained from both
groups of animals ingested latex.
Discussion
Uremia is commonly believed to contribute to an increased
susceptibility to infection but a direct effect on host immunity
has been difficult to demonstrate. In the present experiments,
an animal model has been used to assess the effect of stable
severe uremia on the inflammatory response and phagocytic
systems. Leukocyte mobilization into sponges and the response
to leukocytosis promoting protein (LPP) allowed the inflamma-
tory response in vivo to be analyzed. Mobilization of leuko-
cytes into implanted sponges was found to be reduced to 50% of
normal 6 hr after implantation, but by 24 hr the response was
normal. Complement levels were measured to determine
whether or not this impaired mobilization resulted from a
deficiency in complement-derived chemotactic factors, but
both total complement and C3 levels were in fact normal.
Animals were then challenged with the LPP of Bordetella
pertussis to evaluate the leukocytic response to this stimulus.
The resulting leukocytosis, however, was similar in uremic and
control animals. The mononuclear phagocytic system was
assessed by determining the rate of clearance of '251-labelled
microaggregated human serum albumin (125J MiAHSA) and
bacteriophage ØX174. Clearance of 1251 MiAHSA by the uremic
animals was normal although catabolism of the agent was
reduced significantly. There was also a small but significant
reduction in the ability of severely uremic animals to clear an
intravenous challenge of bacteriophage ØX174. The phagocytic
and bactericidal capability of polymorphonuclear cells was
measured in vitro by latex ingestion and phagocytosis and
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killing of Staph. aureus. In vivo function was also examined by
determining host ability to clear viable E. coli from subcutane-
ously implanted sponges. No significant difference in the ability
of contol or uremic animals to phagocytose and kill micro-
organisms could be demonstrated in these assays. These results
have been summarized in Table 2.
Our studies of the inflammatory response, in vivo, demon-
strated a marked decrease in the ability of PMN leukocytes to
accumulate at an inflammatory site. Leukopenia per se could
have led to such a decrease but the hematological data showed
an increase in leukocyte numbers and argues against this (Fig.
2). A further possibility was that complement-derived chemo-
tactic factors were reduced but, on examination, complement
and C3 levels were normal. Previous studies of chemotaxis in
chronic uremia have been limited to in vitro studies of patients
with chronic renal failure of varying etiology. Although some
investigators [19, 20] found migration inhibitory factors in
uremic serum, others [21, 22] reported normal chemotaxis in
the majority of patients investigated. The defect we have
demonstrated in our animal model was seen only in the first 24
hr after sponge implantation. However, early events in the
establishment of infection are critical [23, 24] and deficiency of
the order observed (50%) could compromise the ability of the
uremia host to contain opportunistic infections.
No differences were detected in the ability of control or
uremic animals to respond to a challenge with LPP. This
component of Bordetella pertussis has been isolated and char-
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Fig. 7. The in vivo clearance of E. coIl from subcutaneously implanted
sponges. Sponges were infected with 500 50 E. coil and removed 12,
24, 72 and 96 hr after implantation in sham-operated controls •, or
uremic 0 animals.
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Table 2. Effect of chronic uremia on the inflammatory response and phagocytosis in an experimental model
Host response Immune component Test system Status in uremia
Inflammatory response Chemotactic response Mobilization into subcutaneous sponges Depressed up to 15 hr (P < 0.01)
Complement system CH 50
C3 level
Normal
Normal
Peripheral blood leukocytic
response
Response to Bordetella perrussis LPP Normal
Phagocytosis Mononuclear phagocytic
cells
Catabolism of 1251 MiAHSA Depressed (P < 0.01)
Clearance of 125J MiAHSA Normal
Clearance of ØX174 Depressed (P < 0.05)
Polymorphonuclear leuko-
cytes
Clearance of E. coli from sponges Normal
In vitro killing of Staph. aureus Normal
In vitro ingestion of latex Normal
acterized by Morse and Morse [12], Morse [25], and Kong and
Morse [26] but has not been used previously for testing immune
function in an immune compromised host. The protein could be
potentially useful for quantitating the ability of the host to
produce a peripheral blood leukocytosis in response to an
inflammatory stimulus but will need further evaluation in other
systems.
Limited studies have been carried out in humans of the
uremic effect on the mononuclear phagocyte system; what data
is available is conflicting. Lahnborg et al [27] found no differ-
ences in the clearance rates of 125J MiAHSA in patients with
chronic renal failure whereas Drivas et a! [28] claimed that
phagocytic function of the RES in dialyzed and conservatively
treated patients with renal failure was actually increased. In
another study, Drivas, Kerr, and Wardle [29] investigated RES
function in patients with glomerulonephritis and found that an
increase in RES function was associated with proliferative and
membranous nephritis. This was attributed to the occurrence of
circulating immune complexes and continued antigenic stimula-
tion. Conflicting reports have also come from studies in experi-
mentally induced uremia. The rate of vascular clearance of 99
mTc was increased in uremic rats [30] but, in another series of
experiments using the same model, the clearance of 1251 Rose-
Bengal was found to be decreased [31]. No differences in the
clearance rates of colloidal carbon or 51Cr-labelled red blood
cells was demonstrated in uremic mice [32]. The finding of
depressed catabolism of 1251 MiAHSA in the presence of
normal phagocytic function was difficult to explain. Had both
functions been depressed, factors such as depletion of opso-
nins, increased rate of hepatic blood flow, or release of RES
depressing substances could have been considered. One possi-
ble explanation, however, is that cytometabolism is disturbed.
Attachment of a particle to the membrane of the phagocytic cell
is energy independent while ingestion and catabolism is energy
dependent [33]. It is possible therefore that the depressed
catabolic function observed is the result of impaired RES cell
metabolism in the liver due to the build up of uremic toxins.
This defect does not extend to systemic macrophages as
sponge-derived cells phagocytosed and killed Staph. aureus
normally.
There was no evidence to suggest a defect in PMN leukocyte
function in the uremic model. Neutrophils obtained from im-
planted sponges were able to ingest latex particles and phagocy-
tose and kill Staph. aureus. In vivo studies using E. coli
infected sponges confirmed these findings. Phagocytic function
has been studied in uremic patients but analyses have been
restricted to the examination of cells from peripheral blood. The
results reported by different groups have been difficult to
compare because of varying clinical management protocols, but
most authors have found little or no impairment of neutrophil
function [34—37].
Despite considerable research effort, the effect of uremia on
host immunity is still unclear. Evidence for an impairment of
immune capability in uremia can be found in the literature, and
it is reasonable to accept that uremia is a reliable indicator of
eventual compromised host immune status. Having said that,
there is little direct evidence to show that uremia, of itself, is a
contributing factor. In this study we have evaluated the effect of
uremia on phagocytosis and the inflammatory response using a
standardized experimental model. The experiments comple-
ment our previous investigation of the effect of uremia on
humoral and cell-mediated immunity and define further the
immune status of this complicated host.
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